Author:
Pavlick Anna C.,Wu Jennifer,Roberts John,Rosenthal Mark A.,Hamilton Anne,Wadler Scott,Farrell Kathleen,Carr Michelle,Fry David,Murgo Anthony J.,Oratz Ruth,Hochster Howard,Liebes Leonard,Muggia Franco
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference41 articles.
1. Aeder SE, Martin PM, Soh JW, Hussaini IM (2004) PKC-η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 23:9062–9069
2. Basu A, Lazo JS (1992) Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum (II) by bryostatin 1. Cancer Res 52:3119–3124
3. Corbett AH, Fernald AW, Osheroff N (1993) Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation. Biochemistry 32:2090–2097
4. Dale IL, Bradshaw TD, Gescher A, Pettit GR (1989) Comparison of effects of bryostatins 1 and 2 and 12–O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res 49:3242–3245
5. El-Rayes BF, Gadgeel S, Shields AF, Manza S, Lorusso P, Philip PA (2006) Phase I study of bryostatin 1 and gemcitabine. Clin Cancer Res 12:7059–7062
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献